Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kuroda K et al. – Constitutively activated Akt might prevent the antitumor efficacy of gefitinib in renal cell carcinoma, and the therapeutic effectiveness of gefitinib might be improved by inhibiting Akt activation.

Related Articles

A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment
Cancer Chemotherapy and Pharmacology, 11/18/09    Relevance Score: 68%

Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09    Relevance Score: 68%

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09    Relevance Score: 68%

Incidence of Cancer in Finnish Families with Clinically Aggressive and Nonaggressive Prostate Cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09    Relevance Score: 67%

The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09    Relevance Score: 67%

Today in Hematology/Oncology...keeping you current

Update on novel agents in renal cell carcinoma
Expert Review of Anticancer Therapy, 12/08/09

Imprint cytologic features of chromophobe renal cell carcinoma morphologically resembling renal oncocytoma: Is this an oncocytic variant of chromophobe renal cell carcinoma
Diagnostic Cytopathology, 12/08/09

Carcinoid tumor of the kidney: An unusual renal tumor
Indian Journal of Urology, 12/08/09

Today in Pharmacology/kinetics...keeping you current

Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients
Nephrology Dialysis Transplantation, 12/08/09

Impact of anti-angiogenic treatments on metastatic renal cell carcinoma
Expert Review of Anticancer Therapy, 12/08/09

Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: An in vitro study
The International Journal of Artificial Organs, 12/07/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address